First-Ever Successful Huntingtonβs Disease Treatment Slows Progression by 75 Percent
For decades, Huntingtonβs disease has stood as one of medicineβs most heartbreaking diagnoses, a slow and unstoppable decline that robs individuals of movement, memory, and personality. Now, for the first time, scientists have achieved something once thought impossible: slowing the diseaseβs progression by 75 percent. In early clinical trials, an experimental gene therapy called AMT-130…











